Meanwhile, a three-biomarker panel (TNF-α, IL-6, and AGEs) achieved approximately 85% sensitivity and specificity in distinguishing DCM patients from diabetic patients with normal cardiac function. The gene discussed is TNF; the disease is familial dilated cardiomyopathy.